Sign in
Enrolling by invitationNo phase

Reminder Tool for Liver Cancer Screening Ultrasounds in Patients With Cirrhosis

Tests a computer prompt that reminds staff to order liver ultrasounds in adults with cirrhosis.

Key facts

Who runs it
NYU Langone Health
Where
New York, United StatesSee the site
Trial code
Registry title
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Status
Enrolling by invitation
People taking part
1,300 people, planned
Started
20 Nov 2024
Planned end
24 Jul 2026
Type of study
Observational, 2 groups
Treatments tested
  • Auto-pended bot liver ultrasound order
Record updated
27 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with cirrhosis who had their last liver imaging 6 months ago or more. It tests a prompt that helps doctors order liver cancer screening.

Age
18 years or older
Sex
All sexes can join
Disease stage
Cirrhosis diagnosis
Earlier treatment
Last imaging was 6 months or more ago. No previous liver transplant.

Main reasons for not taking part

  • Previous liver transplant
  • Diagnosis of hepatocellular carcinoma (HCC)
  • Receiving hospice care
  • Had outside imaging in the past 6 months

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • cirrhosis diagnosis,
  • 6 months or more after since most recent imaging

Who cannot take part

  • previous liver transplant,
  • receiving hospice care,
  • HCC diagnosis,
  • completed external imaging in the past 6 months

Where in United States

  • NYU Langone HealthNew York, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

The 2 groups in the trial

  • Intervention: Auto-pended bot liver ultrasound order

    Participants in the intervention group will receive an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening.

    Treatment: Auto-pended bot liver ultrasound order

  • Control: Usual Care

    Participants in the control group will not receive the auto-pended bot liver ultrasound order.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Plain-language title
Reminder Tool for Liver Cancer Screening Ultrasounds in Patients With CirrhosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
27 February 2026